Journal article icon

Journal article

The epidemiology and clinical burden of human adenovirus respiratory infections among hospitalized children under 5 years in Jordan

Abstract:
Background:
Human Adenovirus (HAdV) is a significant pathogen associated with severe acute respiratory infections, especially in children under 5. Despite its global impact, its epidemiological and clinical burden in Jordan, particularly post-COVID-19, is limited.

Methods:
We conducted a multicenter cross-sectional study across 4 hospitals in Jordan from November 2022 to April 2023. Nasopharyngeal swabs were collected from children <5 years old hospitalized with respiratory symptoms. HAdV positivity was determined using real-time polymerase chain reaction. Demographic, clinical and laboratory data were analyzed to identify predictors of HAdV positivity and complications.

Results:
Among 1000 enrolled participants (median age 9.68 months, 59% male), the HAdV positivity rate was 10.9%, highest in children 49–60 months of age. HAdV-positive cases had higher rates and longer duration of sore throat compared with HAdV-negative cases. Coinfections with respiratory syncytial viruses or influenza were present in 34.9% of HAdV-positive cases and were associated with increased rates of cough, wheezing and respiratory crackles. Logistic regression revealed lower odds of HAdV positivity in children under six months [odds ratio (OR) 0.31, P < 0.001], while invasive ventilation was associated with higher odds of positivity (OR 5.01, P < 0.001). HAdV infection without coinfection was associated with reduced odds of complications (OR 0.06, P < 0.001).

Conclusions:
This is the first comprehensive study in Jordan to document the epidemiologic and clinical burden of HAdV in children post-COVID-19. HAdV remains a major cause of respiratory morbidity, with significant coinfection rates. Further research is needed to explore the nonrespiratory manifestations, identify HAdV common local serotypes and genetic characteristics.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1097/inf.0000000000005020

Authors

More by this author
Role:
Author
ORCID:
0000-0003-2437-5547
More by this author
Role:
Author
ORCID:
0009-0006-5683-1630
More by this author
Role:
Author
ORCID:
0000-0002-3658-5675
More by this author
Role:
Author
ORCID:
0009-0000-7246-622X


More from this funder
Funder identifier:
https://ror.org/008g9ns82
Grant:
884/2024
More from this funder
Funder identifier:
https://ror.org/004nn4n27
Grant:
101057


Publisher:
Lippincott, Williams & Wilkins
Journal:
The Pediatric Infectious Disease Journal More from this journal
Volume:
45
Issue:
3
Pages:
229-235
Place of publication:
United States
Publication date:
2025-10-22
Acceptance date:
2025-09-09
DOI:
EISSN:
1532-0987
ISSN:
0891-3668
Pmid:
41121498


Language:
English
Keywords:
Pubs id:
2308407
UUID:
uuid_80f09552-3b80-417e-82e0-06f589d24675
Local pid:
pubs:2308407
Deposit date:
2025-12-02
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP